A detailed history of Ubs Group Ag transactions in Boston Scientific Corp stock. As of the latest transaction made, Ubs Group Ag holds 320,212 shares of BSX stock, worth $28.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
320,212
Previous 7,139,924 95.52%
Holding current value
$28.5 Million
Previous $550 Million 95.12%
% of portfolio
0.01%
Previous 0.14%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $46.1 Million - $53.1 Million
631,888 Added 8.85%
7,771,812 $651 Million
Q2 2024

Aug 13, 2024

SELL
$67.33 - $77.71 $43 Million - $49.6 Million
-638,461 Reduced 8.21%
7,139,924 $550 Million
Q1 2024

May 13, 2024

BUY
$57.6 - $68.62 $41.9 Million - $49.9 Million
726,746 Added 10.31%
7,778,385 $533 Million
Q4 2023

Feb 09, 2024

BUY
$48.64 - $57.81 $74.5 Million - $88.5 Million
1,531,625 Added 27.75%
7,051,639 $408 Million
Q3 2023

Nov 09, 2023

SELL
$50.19 - $54.68 $9.91 Million - $10.8 Million
-197,537 Reduced 3.45%
5,520,014 $291 Million
Q2 2023

Aug 11, 2023

BUY
$49.72 - $54.64 $2.17 Million - $2.38 Million
43,643 Added 0.77%
5,717,551 $309 Million
Q1 2023

May 12, 2023

SELL
$45.09 - $50.03 $11.4 Million - $12.6 Million
-251,847 Reduced 4.25%
5,673,908 $284 Million
Q4 2022

Feb 08, 2023

BUY
$39.56 - $47.22 $29.9 Million - $35.7 Million
756,716 Added 14.64%
5,925,755 $274 Million
Q3 2022

Nov 10, 2022

SELL
$36.71 - $109.66 $12.3 Million - $36.6 Million
-334,078 Reduced 6.07%
5,169,039 $200 Million
Q2 2022

Aug 10, 2022

SELL
$35.24 - $47.1 $454,701 - $607,731
-12,903 Reduced 0.23%
5,503,117 $205 Million
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $8.4 Million - $9.26 Million
205,393 Added 3.87%
5,516,020 $244 Million
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $20.9 Million - $24.6 Million
548,414 Added 11.52%
5,310,627 $226 Million
Q3 2021

Nov 15, 2021

BUY
$41.23 - $45.88 $20.1 Million - $22.4 Million
488,690 Added 11.44%
4,762,213 $207 Million
Q2 2021

Aug 13, 2021

BUY
$38.58 - $44.24 $34.6 Million - $39.7 Million
897,913 Added 26.6%
4,273,523 $183 Million
Q1 2021

May 12, 2021

BUY
$35.27 - $39.67 $70.4 Million - $79.2 Million
1,995,916 Added 144.66%
3,375,610 $130 Million
Q4 2020

Feb 11, 2021

SELL
$33.15 - $41.97 $7.52 Million - $9.52 Million
-226,933 Reduced 14.12%
1,379,694 $49.6 Million
Q3 2020

Nov 12, 2020

SELL
$34.44 - $42.23 $10 Million - $12.3 Million
-290,837 Reduced 15.33%
1,606,627 $61.4 Million
Q2 2020

Jul 31, 2020

BUY
$30.19 - $39.11 $12 Million - $15.5 Million
396,890 Added 26.45%
1,897,464 $66.6 Million
Q1 2020

May 01, 2020

SELL
$25.83 - $45.71 $14.5 Million - $25.7 Million
-561,849 Reduced 27.24%
1,500,574 $49 Million
Q4 2019

Feb 14, 2020

SELL
$37.87 - $45.37 $12.2 Million - $14.6 Million
-322,119 Reduced 13.51%
2,062,423 $93.3 Million
Q3 2019

Nov 14, 2019

BUY
$40.31 - $43.45 $3.25 Million - $3.5 Million
80,524 Added 3.49%
2,384,542 $97 Million
Q2 2019

Aug 14, 2019

SELL
$34.91 - $42.98 $3.36 Million - $4.14 Million
-96,278 Reduced 4.01%
2,304,018 $99 Million
Q1 2019

May 14, 2019

BUY
$32.91 - $40.75 $14.5 Million - $18 Million
440,812 Added 22.5%
2,400,296 $92.1 Million
Q4 2018

Feb 14, 2019

SELL
$31.73 - $39.04 $6.37 Million - $7.83 Million
-200,690 Reduced 9.29%
1,959,484 $69.2 Million
Q3 2018

Nov 14, 2018

BUY
$32.83 - $38.63 $9.44 Million - $11.1 Million
287,614 Added 15.36%
2,160,174 $83.2 Million
Q2 2018

Aug 14, 2018

BUY
$26.84 - $34.32 $21.1 Million - $27 Million
787,397 Added 72.56%
1,872,560 $61.2 Million
Q1 2018

May 15, 2018

SELL
$25.2 - $28.54 $637,736 - $722,261
-25,307 Reduced 2.28%
1,085,163 $29.6 Million
Q4 2017

Feb 14, 2018

SELL
$24.79 - $29.8 $7.45 Million - $8.95 Million
-300,329 Reduced 21.29%
1,110,470 $27.5 Million
Q3 2017

Nov 14, 2017

SELL
$26.26 - $29.17 $4.71 Million - $5.23 Million
-179,440 Reduced 11.28%
1,410,799 $41.2 Million
Q2 2017

Aug 14, 2017

BUY
N/A
237,094 Added 17.52%
1,590,239 $44.1 Million
Q1 2017

Nov 14, 2017

BUY
N/A
1,353,145
1,353,145 $33.7 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $127B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.